newsfilter
← Latest News
GlobeNewswire·

Fate Therapeutics Appoints Laura Hamill to Board of Directors

SAN DIEGO, June 15, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell